Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study).

Diabetes, obesity & metabolism·2026

Same author

Erythropoiesis-stimulating agents to reduce heart failure hospitalization: a systematic review and meta-analysis.

European journal of heart failure·2026

Same author

Combination of heart failure and atrial fibrillation worsens ethnicity-related disparity: an individual patient-level meta-analysis of randomized trials.

European journal of heart failure·2026

Same author

Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.

Neuro-oncology practice·2025

Same author

Decline in alcoholic cardiomyopathy mortality in Europe: no time for complacency.

European heart journal. Quality of care & clinical outcomes·2025

Same author

The importance of intravenous glucose tolerance test glucose stimulus for the evaluation of insulin secretion.

Scientific reports·2024

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2

Robert S Elkeles¹, Ian F Godsland, Michael D Feher

¹Endocrinology and Metabolic Medicine, Imperial College London, St Mary's Hospital, London, UK. robert.elkeles@imperial.nhs.uk

European Heart Journal

|June 25, 2008

Summary

This summary is machine-generated.

Coronary artery calcification score (CACS) strongly predicts cardiovascular events in type 2 diabetes (T2DM) patients. Adding CACS to existing risk models significantly improves cardiovascular event prediction.

More Related Videos

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images

Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images

Published on: September 22, 2023

Related Experiment Videos

Last Updated: Jun 23, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images

Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images

Published on: September 22, 2023

Area of Science:

Cardiology
Endocrinology
Preventive Medicine

Background:

Type 2 diabetes (T2DM) significantly increases cardiovascular disease (CVD) risk.
Accurate risk stratification is crucial for preventing CVD events in T2DM patients.
Established risk models may not fully capture individual CVD risk in T2DM.

Purpose of the Study:

To evaluate the predictive value of coronary artery calcification score (CACS) for cardiovascular events in asymptomatic T2DM patients.
To determine if CACS improves risk prediction beyond traditional risk factors and models.

Main Methods:

Prospective cohort study (PREDICT Study) of 589 T2DM patients without prior CVD.
Measured CACS and various risk factors (lipids, HOMA-IR, urine albumin-creatinine ratio).
Followed participants for a median of 4 years to identify first coronary heart disease and stroke events.

Main Results:

CACS was a significant independent predictor of cardiovascular events (P < 0.001).
Higher CACS levels were associated with substantially increased event risk (e.g., CACS >1000 AU showed 19.8-fold risk).
CACS improved the area under the ROC curve from 0.63 to 0.73 compared to the UKPDS risk engine alone (P = 0.03).

Conclusions:

Coronary artery calcification scoring is a powerful tool for predicting cardiovascular events in asymptomatic T2DM individuals.
CACS enhances the predictive capability of established cardiovascular risk assessment models in this population.